With so little known about the Chinese vaccines, the strategy of ‘vaccine diplomacy’ could come back to haunt Beijing.
Everything about Indonesia’s first Covid-19 inoculation was choreographed for the cameras. Sitting in front of flowers and a red sign that read “Vaccine: Safe and Halal,” Joko Widodo, Indonesia’s president, slowly rolled up his white shirt sleeve as the medical professional next to him held up a small box to the assembled audience. The box, which contained the president’s vaccine dose, was embossed with a single, Chinese brand: Sinovac.
It was January, and with Indonesia’s C
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
In 2021, after four decades of exponential growth in China’s economy, Xi Jinping revived the party slogan “common prosperity” in order to address the country’s glaring inequality. The policy priority was suddenly everywhere: in speeches, in newspapers and in schools. But now, three years later, it has all but disappeared from public discourse even as the country’s economic inequality festers. What happened?
The researcher and former OpenAI board member discusses who holds the advantage in artificial intelligence and the chances of the U.S. and China working together to regulate the technology.
On-Demand Webinar: Strategies for Identifying Military End Users
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy